Main > ONCOLOGY (**) > Lung>NSCLC>Squamous>MET> > TREAT.: > USA. M. PembrolizuMAb+

---

USA. M. PembrolizuMAb+'s subsections
(*) EU Approval Date: 2019. 03.14
(*) USA Approval Date: 2018. 10.30
+Carboplatin+(Nab)Paclitaxel
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 10.30
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb+'s products
This section has no products